Sao Tome and Principe
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
7.13 (5.85 - 8.41) | 2019 | Modelled | IHME |
7.84 (6.45 - 9.27) | 2018 | Modelled | IHME |
8.15 (6.66 - 9.65) | 2017 | Modelled | IHME |
8.08 (6.65 - 9.39) | 2016 | Modelled | IHME |
8.01 (6.55 - 9.29) | 2015 | Modelled | IHME |
8.12 (6.70 - 9.35) | 2014 | Modelled | IHME |
8.39 (6.93 - 9.68) | 2013 | Modelled | IHME |
8.75 (7.23 - 10.11) | 2012 | Modelled | IHME |
9.13 (7.54 - 10.58) | 2011 | Modelled | IHME |
9.46 (7.73 - 11.04) | 2010 | Modelled | IHME |
9.75 (8.02 - 11.31) | 2009 | Modelled | IHME |
10.02 (8.31 - 11.68) | 2008 | Modelled | IHME |
10.3 (8.54 - 12.03) | 2007 | Modelled | IHME |
10.58 (8.77 - 12.46) | 2006 | Modelled | IHME |
10.86 (8.97 - 12.85) | 2005 | Modelled | IHME |
11.17 (9.27 - 13.16) | 2004 | Modelled | IHME |
11.5 (9.60 - 13.43) | 2003 | Modelled | IHME |
11.81 (9.87 - 13.84) | 2002 | Modelled | IHME |
12.09 (10.06 - 14.20) | 2001 | Modelled | IHME |
12.3 (10.10 - 14.58) | 2000 | Modelled | IHME |
12.46 (10.17 - 14.70) | 1999 | Modelled | IHME |
12.6 (10.22 - 14.93) | 1998 | Modelled | IHME |
12.72 (10.23 - 15.12) | 1997 | Modelled | IHME |
12.82 (10.22 - 15.31) | 1996 | Modelled | IHME |
12.88 (10.20 - 15.47) | 1995 | Modelled | IHME |
12.93 (10.33 - 15.42) | 1994 | Modelled | IHME |
12.98 (10.37 - 15.39) | 1993 | Modelled | IHME |
13.02 (10.45 - 15.34) | 1992 | Modelled | IHME |
13.07 (10.53 - 15.39) | 1991 | Modelled | IHME |
13.1 (10.60 - 15.43) | 1990 | Modelled | IHME |
3.54 (0.29 - 24.66) | 2015 | Modelled | WHO |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.93 (0.66 - 1.19) | 2019 | Modelled | IHME |
1.01 (0.74 - 1.28) | 2018 | Modelled | IHME |
1.06 (0.78 - 1.35) | 2017 | Modelled | IHME |
1.07 (0.81 - 1.36) | 2016 | Modelled | IHME |
1.08 (0.82 - 1.41) | 2015 | Modelled | IHME |
1.09 (0.84 - 1.42) | 2014 | Modelled | IHME |
1.12 (0.85 - 1.44) | 2013 | Modelled | IHME |
1.15 (0.86 - 1.47) | 2012 | Modelled | IHME |
1.19 (0.88 - 1.53) | 2011 | Modelled | IHME |
1.24 (0.89 - 1.59) | 2010 | Modelled | IHME |
1.34 (0.96 - 1.71) | 2009 | Modelled | IHME |
1.52 (1.10 - 1.92) | 2008 | Modelled | IHME |
1.77 (1.30 - 2.25) | 2007 | Modelled | IHME |
2.1 (1.56 - 2.69) | 2006 | Modelled | IHME |
2.49 (1.85 - 3.24) | 2005 | Modelled | IHME |
3.45 (2.58 - 4.38) | 2004 | Modelled | IHME |
5.16 (3.87 - 6.49) | 2003 | Modelled | IHME |
7.08 (5.33 - 8.81) | 2002 | Modelled | IHME |
8.72 (6.54 - 10.93) | 2001 | Modelled | IHME |
9.56 (7.07 - 12.10) | 2000 | Modelled | IHME |
9.8 (7.15 - 12.41) | 1999 | Modelled | IHME |
9.99 (7.25 - 12.69) | 1998 | Modelled | IHME |
10.14 (7.32 - 12.94) | 1997 | Modelled | IHME |
10.24 (7.31 - 13.12) | 1996 | Modelled | IHME |
10.3 (7.31 - 13.29) | 1995 | Modelled | IHME |
10.34 (7.45 - 13.20) | 1994 | Modelled | IHME |
10.37 (7.64 - 13.16) | 1993 | Modelled | IHME |
10.4 (7.69 - 13.14) | 1992 | Modelled | IHME |
10.41 (7.81 - 13.18) | 1991 | Modelled | IHME |
10.42 (7.83 - 13.30) | 1990 | Modelled | IHME |
1.36 (0.11 - 11.62) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
15,925 (12,887 - 18,747) | 1990 | Modelled | IHME |
16,206 (13,059 - 19,084) | 1991 | Modelled | IHME |
16,458 (13,202 - 19,382) | 1992 | Modelled | IHME |
16,687 (13,336 - 19,788) | 1993 | Modelled | IHME |
16,900 (13,500 - 20,161) | 1994 | Modelled | IHME |
17,102 (13,538 - 20,540) | 1995 | Modelled | IHME |
17,273 (13,776 - 20,633) | 1996 | Modelled | IHME |
17,396 (13,992 - 20,681) | 1997 | Modelled | IHME |
17,483 (14,178 - 20,722) | 1998 | Modelled | IHME |
17,548 (14,324 - 20,716) | 1999 | Modelled | IHME |
17,604 (14,462 - 20,871) | 2000 | Modelled | IHME |
17,600 (14,639 - 20,664) | 2001 | Modelled | IHME |
17,505 (14,630 - 20,512) | 2002 | Modelled | IHME |
17,357 (14,489 - 20,285) | 2003 | Modelled | IHME |
17,197 (14,268 - 20,265) | 2004 | Modelled | IHME |
17,070 (14,091 - 20,191) | 2005 | Modelled | IHME |
16,977 (14,069 - 19,985) | 2006 | Modelled | IHME |
16,883 (13,997 - 19,713) | 2007 | Modelled | IHME |
16,780 (13,917 - 19,556) | 2008 | Modelled | IHME |
16,662 (13,712 - 19,344) | 2009 | Modelled | IHME |
16,524 (13,494 - 19,271) | 2010 | Modelled | IHME |
16,275 (13,441 - 18,857) | 2011 | Modelled | IHME |
15,909 (13,142 - 18,381) | 2012 | Modelled | IHME |
15,550 (12,844 - 17,948) | 2013 | Modelled | IHME |
15,335 (12,662 - 17,659) | 2014 | Modelled | IHME |
15,410 (12,605 - 17,869) | 2015 | Modelled | IHME |
15,817 (13,011 - 18,373) | 2016 | Modelled | IHME |
16,222 (13,249 - 19,198) | 2017 | Modelled | IHME |
15,857 (13,045 - 18,741) | 2018 | Modelled | IHME |
14,651 (12,007 - 17,274) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
11.3 (7.78 - 15.60) | 2019 | Modelled | IHME |
11.3 (7.79 - 15.40) | 2018 | Modelled | IHME |
11.2 (7.71 - 15.30) | 2017 | Modelled | IHME |
11.2 (7.72 - 15.30) | 2016 | Modelled | IHME |
11.3 (7.98 - 15.50) | 2015 | Modelled | IHME |
11.9 (8.69 - 15.90) | 2014 | Modelled | IHME |
12.4 (9.37 - 16.20) | 2013 | Modelled | IHME |
13.1 (10.20 - 17) | 2012 | Modelled | IHME |
14.1 (11.10 - 18.10) | 2011 | Modelled | IHME |
15.1 (11.80 - 19.40) | 2010 | Modelled | IHME |
15.4 (12 - 19.70) | 2009 | Modelled | IHME |
15.8 (12.10 - 20.40) | 2008 | Modelled | IHME |
16.5 (12.60 - 21.30) | 2007 | Modelled | IHME |
16.8 (12.70 - 21.90) | 2006 | Modelled | IHME |
16.4 (12.40 - 21.50) | 2005 | Modelled | IHME |
17.7 (13.30 - 23.10) | 2004 | Modelled | IHME |
17.8 (13.40 - 23.50) | 2003 | Modelled | IHME |
18.8 (14.20 - 24.90) | 2002 | Modelled | IHME |
19 (14.40 - 25.30) | 2001 | Modelled | IHME |
19.1 (14.50 - 25.30) | 2000 | Modelled | IHME |
19.5 (14.80 - 25.80) | 1999 | Modelled | IHME |
19.5 (14.80 - 25.90) | 1998 | Modelled | IHME |
19.2 (14.50 - 25.40) | 1997 | Modelled | IHME |
19 (14.10 - 25.20) | 1996 | Modelled | IHME |
18.7 (13.80 - 25.10) | 1995 | Modelled | IHME |
18.7 (13.10 - 25.70) | 1994 | Modelled | IHME |
18.8 (13.50 - 25.80) | 1993 | Modelled | IHME |
19.1 (13.30 - 26.30) | 1992 | Modelled | IHME |
19.2 (12.60 - 26.70) | 1991 | Modelled | IHME |
19.3 (13.30 - 27.20) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
23 (16 - 32) | 2019 | Modelled | IHME |
23 (16 - 31) | 2018 | Modelled | IHME |
22 (15 - 30) | 2017 | Modelled | IHME |
22 (15 - 30) | 2016 | Modelled | IHME |
22 (15 - 30) | 2015 | Modelled | IHME |
22 (16 - 30) | 2014 | Modelled | IHME |
23 (17 - 30) | 2013 | Modelled | IHME |
24 (19 - 31) | 2012 | Modelled | IHME |
25 (20 - 32) | 2011 | Modelled | IHME |
26 (21 - 34) | 2010 | Modelled | IHME |
26 (21 - 34) | 2009 | Modelled | IHME |
26 (20 - 34) | 2008 | Modelled | IHME |
27 (21 - 35) | 2007 | Modelled | IHME |
27 (20 - 35) | 2006 | Modelled | IHME |
26 (19 - 34) | 2005 | Modelled | IHME |
27 (21 - 36) | 2004 | Modelled | IHME |
27 (20 - 36) | 2003 | Modelled | IHME |
28 (21 - 37) | 2002 | Modelled | IHME |
28 (21 - 37) | 2001 | Modelled | IHME |
27 (21 - 36) | 2000 | Modelled | IHME |
28 (21 - 36) | 1999 | Modelled | IHME |
27 (21 - 36) | 1998 | Modelled | IHME |
26 (20 - 35) | 1997 | Modelled | IHME |
26 (19 - 34) | 1996 | Modelled | IHME |
25 (18 - 33) | 1995 | Modelled | IHME |
24 (17 - 34) | 1994 | Modelled | IHME |
24 (17 - 33) | 1993 | Modelled | IHME |
24 (17 - 33) | 1992 | Modelled | IHME |
24 (16 - 33) | 1991 | Modelled | IHME |
24 (16 - 33) | 1990 | Modelled | IHME |
30 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
49 (41 - 57) | 2019 | Modelled | IHME |
49 (41 - 57) | 2018 | Modelled | IHME |
49 (41 - 57) | 2017 | Modelled | IHME |
49 (41 - 57) | 2016 | Modelled | IHME |
49 (41 - 57) | 2015 | Modelled | IHME |
49 (41 - 57) | 2014 | Modelled | IHME |
49 (41 - 58) | 2013 | Modelled | IHME |
49 (41 - 58) | 2012 | Modelled | IHME |
49 (41 - 58) | 2011 | Modelled | IHME |
50 (41 - 58) | 2010 | Modelled | IHME |
49 (41 - 58) | 2009 | Modelled | IHME |
49 (41 - 58) | 2008 | Modelled | IHME |
49 (41 - 57) | 2007 | Modelled | IHME |
49 (41 - 57) | 2006 | Modelled | IHME |
48 (40 - 57) | 2005 | Modelled | IHME |
49 (41 - 57) | 2004 | Modelled | IHME |
49 (41 - 57) | 2003 | Modelled | IHME |
49 (41 - 58) | 2002 | Modelled | IHME |
49 (41 - 58) | 2001 | Modelled | IHME |
49 (41 - 58) | 2000 | Modelled | IHME |
49 (41 - 58) | 1999 | Modelled | IHME |
49 (41 - 58) | 1998 | Modelled | IHME |
49 (41 - 58) | 1997 | Modelled | IHME |
49 (40 - 57) | 1996 | Modelled | IHME |
49 (40 - 58) | 1995 | Modelled | IHME |
49 (40 - 58) | 1994 | Modelled | IHME |
49 (40 - 58) | 1993 | Modelled | IHME |
49 (40 - 58) | 1992 | Modelled | IHME |
49 (41 - 58) | 1991 | Modelled | IHME |
49 (41 - 58) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of HepB birth dose
Coverage of 3-dose hepatitis B vaccine
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
2.4 (1.92 - 3) | 2019 | Modelled | IHME |
2.39 (1.92 - 2.99) | 2018 | Modelled | IHME |
2.39 (1.92 - 2.99) | 2017 | Modelled | IHME |
2.38 (1.92 - 2.97) | 2016 | Modelled | IHME |
2.38 (1.91 - 2.98) | 2015 | Modelled | IHME |
2.39 (1.92 - 2.99) | 2014 | Modelled | IHME |
2.4 (1.93 - 3) | 2013 | Modelled | IHME |
2.43 (1.95 - 3.02) | 2012 | Modelled | IHME |
2.45 (1.97 - 3.06) | 2011 | Modelled | IHME |
2.47 (1.98 - 3.08) | 2010 | Modelled | IHME |
2.49 (2 - 3.11) | 2009 | Modelled | IHME |
2.52 (2.02 - 3.14) | 2008 | Modelled | IHME |
2.54 (2.04 - 3.18) | 2007 | Modelled | IHME |
2.57 (2.05 - 3.21) | 2006 | Modelled | IHME |
2.59 (2.06 - 3.25) | 2005 | Modelled | IHME |
2.62 (2.08 - 3.28) | 2004 | Modelled | IHME |
2.64 (2.11 - 3.32) | 2003 | Modelled | IHME |
2.67 (2.14 - 3.37) | 2002 | Modelled | IHME |
2.69 (2.16 - 3.39) | 2001 | Modelled | IHME |
2.71 (2.19 - 3.42) | 2000 | Modelled | IHME |
2.73 (2.20 - 3.45) | 1999 | Modelled | IHME |
2.75 (2.22 - 3.47) | 1998 | Modelled | IHME |
2.76 (2.23 - 3.47) | 1997 | Modelled | IHME |
2.78 (2.25 - 3.49) | 1996 | Modelled | IHME |
2.79 (2.25 - 3.51) | 1995 | Modelled | IHME |
2.8 (2.26 - 3.52) | 1994 | Modelled | IHME |
2.81 (2.27 - 3.53) | 1993 | Modelled | IHME |
2.82 (2.28 - 3.54) | 1992 | Modelled | IHME |
2.83 (2.29 - 3.55) | 1991 | Modelled | IHME |
2.84 (2.28 - 3.56) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.5 (1.23 - 1.68) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
3,451 (2,767 - 4,331) | 1990 | Modelled | IHME |
3,512 (2,842 - 4,405) | 1991 | Modelled | IHME |
3,568 (2,887 - 4,475) | 1992 | Modelled | IHME |
3,618 (2,919 - 4,538) | 1993 | Modelled | IHME |
3,663 (2,956 - 4,596) | 1994 | Modelled | IHME |
3,706 (2,984 - 4,656) | 1995 | Modelled | IHME |
3,745 (3,027 - 4,698) | 1996 | Modelled | IHME |
3,781 (3,051 - 4,751) | 1997 | Modelled | IHME |
3,815 (3,081 - 4,816) | 1998 | Modelled | IHME |
3,850 (3,106 - 4,865) | 1999 | Modelled | IHME |
3,886 (3,128 - 4,900) | 2000 | Modelled | IHME |
3,921 (3,151 - 4,940) | 2001 | Modelled | IHME |
3,957 (3,170 - 4,987) | 2002 | Modelled | IHME |
3,993 (3,183 - 5,016) | 2003 | Modelled | IHME |
4,033 (3,210 - 5,058) | 2004 | Modelled | IHME |
4,076 (3,236 - 5,104) | 2005 | Modelled | IHME |
4,121 (3,296 - 5,152) | 2006 | Modelled | IHME |
4,168 (3,342 - 5,214) | 2007 | Modelled | IHME |
4,215 (3,383 - 5,253) | 2008 | Modelled | IHME |
4,264 (3,415 - 5,316) | 2009 | Modelled | IHME |
4,317 (3,460 - 5,381) | 2010 | Modelled | IHME |
4,367 (3,506 - 5,446) | 2011 | Modelled | IHME |
4,413 (3,548 - 5,495) | 2012 | Modelled | IHME |
4,459 (3,587 - 5,560) | 2013 | Modelled | IHME |
4,513 (3,629 - 5,645) | 2014 | Modelled | IHME |
4,582 (3,683 - 5,739) | 2015 | Modelled | IHME |
4,665 (3,754 - 5,811) | 2016 | Modelled | IHME |
4,752 (3,812 - 5,949) | 2017 | Modelled | IHME |
4,840 (3,882 - 6,040) | 2018 | Modelled | IHME |
4,934 (3,939 - 6,159) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
750 (620 - 850) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
1.75 (1.15 - 2.61) | 2019 | Modelled | IHME |
1.74 (1.15 - 2.59) | 2018 | Modelled | IHME |
1.73 (1.15 - 2.55) | 2017 | Modelled | IHME |
1.69 (1.14 - 2.47) | 2016 | Modelled | IHME |
1.65 (1.11 - 2.45) | 2015 | Modelled | IHME |
1.66 (1.13 - 2.42) | 2014 | Modelled | IHME |
1.62 (1.14 - 2.34) | 2013 | Modelled | IHME |
1.61 (1.16 - 2.31) | 2012 | Modelled | IHME |
1.65 (1.20 - 2.33) | 2011 | Modelled | IHME |
1.73 (1.26 - 2.43) | 2010 | Modelled | IHME |
1.76 (1.27 - 2.46) | 2009 | Modelled | IHME |
1.79 (1.30 - 2.53) | 2008 | Modelled | IHME |
1.87 (1.35 - 2.64) | 2007 | Modelled | IHME |
1.89 (1.36 - 2.68) | 2006 | Modelled | IHME |
1.85 (1.33 - 2.63) | 2005 | Modelled | IHME |
1.98 (1.41 - 2.79) | 2004 | Modelled | IHME |
1.98 (1.40 - 2.80) | 2003 | Modelled | IHME |
2.05 (1.45 - 2.93) | 2002 | Modelled | IHME |
2.05 (1.45 - 2.97) | 2001 | Modelled | IHME |
2.06 (1.45 - 2.96) | 2000 | Modelled | IHME |
2.09 (1.47 - 2.97) | 1999 | Modelled | IHME |
2.08 (1.47 - 2.95) | 1998 | Modelled | IHME |
2.04 (1.43 - 2.87) | 1997 | Modelled | IHME |
2.01 (1.39 - 2.82) | 1996 | Modelled | IHME |
1.98 (1.36 - 2.80) | 1995 | Modelled | IHME |
1.98 (1.29 - 2.81) | 1994 | Modelled | IHME |
1.99 (1.35 - 2.93) | 1993 | Modelled | IHME |
2.03 (1.29 - 2.95) | 1992 | Modelled | IHME |
2.05 (1.30 - 3.02) | 1991 | Modelled | IHME |
2.08 (1.36 - 3.11) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
4 (2 - 5) | 2019 | Modelled | IHME |
4 (2 - 5) | 2018 | Modelled | IHME |
3 (2 - 5) | 2017 | Modelled | IHME |
3 (2 - 5) | 2016 | Modelled | IHME |
3 (2 - 5) | 2015 | Modelled | IHME |
3 (2 - 5) | 2014 | Modelled | IHME |
3 (2 - 4) | 2013 | Modelled | IHME |
3 (2 - 4) | 2012 | Modelled | IHME |
3 (2 - 4) | 2011 | Modelled | IHME |
3 (2 - 4) | 2010 | Modelled | IHME |
3 (2 - 4) | 2009 | Modelled | IHME |
3 (2 - 4) | 2008 | Modelled | IHME |
3 (2 - 4) | 2007 | Modelled | IHME |
3 (2 - 4) | 2006 | Modelled | IHME |
3 (2 - 4) | 2005 | Modelled | IHME |
3 (2 - 4) | 2004 | Modelled | IHME |
3 (2 - 4) | 2003 | Modelled | IHME |
3 (2 - 4) | 2002 | Modelled | IHME |
3 (2 - 4) | 2001 | Modelled | IHME |
3 (2 - 4) | 2000 | Modelled | IHME |
3 (2 - 4) | 1999 | Modelled | IHME |
3 (2 - 4) | 1998 | Modelled | IHME |
3 (2 - 4) | 1997 | Modelled | IHME |
3 (2 - 4) | 1996 | Modelled | IHME |
3 (2 - 4) | 1995 | Modelled | IHME |
3 (2 - 4) | 1994 | Modelled | IHME |
3 (2 - 4) | 1993 | Modelled | IHME |
3 (2 - 4) | 1992 | Modelled | IHME |
3 (2 - 4) | 1991 | Modelled | IHME |
3 (2 - 4) | 1990 | Modelled | IHME |
8 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
15 (11 - 21) | 2019 | Modelled | IHME |
16 (11 - 21) | 2018 | Modelled | IHME |
16 (11 - 21) | 2017 | Modelled | IHME |
16 (11 - 21) | 2016 | Modelled | IHME |
16 (11 - 22) | 2015 | Modelled | IHME |
16 (11 - 22) | 2014 | Modelled | IHME |
16 (11 - 22) | 2013 | Modelled | IHME |
17 (12 - 22) | 2012 | Modelled | IHME |
17 (12 - 22) | 2011 | Modelled | IHME |
17 (11 - 22) | 2010 | Modelled | IHME |
17 (11 - 22) | 2009 | Modelled | IHME |
17 (12 - 22) | 2008 | Modelled | IHME |
17 (12 - 23) | 2007 | Modelled | IHME |
17 (12 - 23) | 2006 | Modelled | IHME |
18 (12 - 24) | 2005 | Modelled | IHME |
17 (12 - 23) | 2004 | Modelled | IHME |
18 (12 - 24) | 2003 | Modelled | IHME |
17 (12 - 23) | 2002 | Modelled | IHME |
18 (12 - 24) | 2001 | Modelled | IHME |
18 (12 - 24) | 2000 | Modelled | IHME |
18 (12 - 24) | 1999 | Modelled | IHME |
18 (12 - 24) | 1998 | Modelled | IHME |
18 (12 - 24) | 1997 | Modelled | IHME |
18 (12 - 24) | 1996 | Modelled | IHME |
18 (13 - 25) | 1995 | Modelled | IHME |
18 (12 - 25) | 1994 | Modelled | IHME |
18 (12 - 25) | 1993 | Modelled | IHME |
18 (12 - 25) | 1992 | Modelled | IHME |
18 (12 - 25) | 1991 | Modelled | IHME |
18 (12 - 25) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.93
(%)
2019, latest modelled
(0.66 - 1.19(%))
IHME
Prevalence PWID
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines